Establishing the Role of Targeted Therapies in Cancer Care | PTCE Pharmacy Connect

Establishing the Role of Targeted Therapies i...

Up next

Cell & Gene Therapy Update with Joe DePinto, InspiroGene by McKesson | TWIRx

Cell and gene therapy has entered a new phase. The science is advancing rapidly, but the harder question is increasingly becoming: How do we actually get these therapies to the right patient, at the right treatment center, with the financing, logistics, clinical support, and foll ...  Show more

PBM Impact on Independent Pharmacy Owners | PBM Reform

A patient's copay unexpectedly jumped to nearly $500. Upon investigation, it was discovered his plan design had changed, penalizing him for using our pharmacy. He was now facing higher costs or needing to switch to a chain or mail-order pharmacy. 

Recommended Episodes

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non-Small Cell Lung Cancer | PTCE Pharmacy Connect
PTCE Pharmacy Connect | Pharmacy Times

Educational Objectives Review recent clinical updates of RET inhibitors and how they fit into the treatment paradigm for non‒small cell lung cancer Identify and manage adverse effects of RET inhibitors to ensure patient safety and improve adherence Faculty Lauren Ledbetter, Pharm ...  Show more

The Impact of COVID-19 Vaccine Hesitancy and Overcoming Patient Barriers | PTCE Connect
PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliv ...  Show more

Bradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/YWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you optimizing the care of your patients with ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors and novel therapies such as tu ...  Show more

Bhavana Pothuri, MD, MS - Expanding the Benefits and Refining the Role of Immune Checkpoint Inhibitors in the Treatment of Recurrent and Advanced Endometrial Cancer
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast

Go online to PeerView.com/KWF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in oncology discusses the role of immune checkpoint inhibitors in the care of patients with recurrent and advanced endo ...  Show more